Teladoc (TDOC) Chief Accounting Officer Joseph Catapano Sells Shares
$TDOC · Teladoc Health, Inc.Research Summary
AI-generated summary of this SEC filing
Teladoc (TDOC) Chief Accounting Officer Joseph Catapano Sells Shares
What Happened
Joseph Ronald Catapano, Teladoc's Chief Accounting Officer, had restricted/performance awards convert to common stock and then sold a small block of shares. The filing shows conversions/exercises of 833 shares and 39 shares (derivative conversions) on Sept 1, 2026, and an open‑market sale of 274 shares on Sept 2, 2026 at $6.30 each, generating $1,726. The conversions/dispositions of 833 and 39 shares are reported at $0 because those shares were used to satisfy tax withholding.
Key Details
- Filing date: Sept 3, 2026 (reporting period: Sept 1, 2026). Filing appears timely.
- Transactions:
- Sept 1, 2026: Conversion/exercise of 833 shares (derivative) and 39 shares (derivative).
- Sept 2, 2026: Open‑market sale of 274 shares at $6.30, proceeds $1,726.
- Two derivative dispositions (833 and 39 shares) reported at $0 — these represent shares delivered to cover tax withholding.
- Shares owned after the transactions: not specified in the provided excerpt.
- Relevant footnotes from the filing:
- F1: Restricted stock units (RSUs) convert one‑for‑one to common shares.
- F2: Performance stock units (PSUs) convert one‑for‑one to common shares.
- F3: Shares were sold to cover the tax‑withholding obligation from vesting.
- F4–F5: Background on the RSU/PSU grants (grant dates and vesting schedules).
Context
The filings show a routine vesting/conversion of RSUs/PSUs followed by share delivery to satisfy taxes (cashless withholding) and a small open‑market sale. Sales to cover withholding are common and do not necessarily indicate a view on the company’s future price. This was not a purchase (which is generally a stronger signal of insider bullishness).